These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15312642)

  • 1. Neuropeptide S: a novel activating anxiolytic?
    Koob GF; Greenwell TN
    Neuron; 2004 Aug; 43(4):441-2. PubMed ID: 15312642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects.
    Xu YL; Reinscheid RK; Huitron-Resendiz S; Clark SD; Wang Z; Lin SH; Brucher FA; Zeng J; Ly NK; Henriksen SJ; de Lecea L; Civelli O
    Neuron; 2004 Aug; 43(4):487-97. PubMed ID: 15312648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide S and its receptor: a newly deorphanized G protein-coupled receptor system.
    Reinscheid RK; Xu YL
    Neuroscientist; 2005 Dec; 11(6):532-8. PubMed ID: 16282594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide S: a novel modulator of stress and arousal.
    Okamura N; Reinscheid RK
    Stress; 2007 Aug; 10(3):221-6. PubMed ID: 17613937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide S as a novel arousal promoting peptide transmitter.
    Reinscheid RK; Xu YL
    FEBS J; 2005 Nov; 272(22):5689-93. PubMed ID: 16279934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiolytic-like effect of neuropeptide S in the rat defensive burying.
    Vitale G; Filaferro M; Ruggieri V; Pennella S; Frigeri C; Rizzi A; Guerrini R; Calò G
    Peptides; 2008 Dec; 29(12):2286-91. PubMed ID: 18793688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide S: a new player in the modulation of arousal and anxiety.
    Reinscheid RK; Xu YL; Civelli O
    Mol Interv; 2005 Feb; 5(1):42-6. PubMed ID: 15731503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain.
    Xu YL; Gall CM; Jackson VR; Civelli O; Reinscheid RK
    J Comp Neurol; 2007 Jan; 500(1):84-102. PubMed ID: 17099900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness.
    Ohno K; Sakurai T
    Front Neuroendocrinol; 2008 Jan; 29(1):70-87. PubMed ID: 17910982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological characterization and mechanisms of the novel antidepressive- and/or anxiolytic-like substances identified from Perillae Herba].
    Tsuji M; Miyagawa K; Takeuchi T; Takeda H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):159-67. PubMed ID: 18800619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ventromedial hypothalamic nucleus plays an important role in anxiolytic-like effect of neuropeptide S.
    Jiang JH; Peng YL; Zhang PJ; Xue HX; He Z; Liang XY; Chang M
    Neuropeptides; 2018 Feb; 67():36-44. PubMed ID: 29195839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptides: implications for alcoholism.
    Cowen MS; Chen F; Lawrence AJ
    J Neurochem; 2004 Apr; 89(2):273-85. PubMed ID: 15056272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon.
    Rajarao SJ; Platt B; Sukoff SJ; Lin Q; Bender CN; Nieuwenhuijsen BW; Ring RH; Schechter LE; Rosenzweig-Lipson S; Beyer CE
    Neuropeptides; 2007 Oct; 41(5):307-20. PubMed ID: 17637475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of neuropeptide S on general anesthesia in rats.
    Kushikata T; Yoshida H; Kudo M; Salvadori S; Calo G; Hirota K
    Anesth Analg; 2011 Apr; 112(4):845-9. PubMed ID: 21288975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel neuropeptide Y Y5 receptor antagonist Lu AA33810 [N-[[trans-4-[(4,5-dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]-methanesulfonamide] exerts anxiolytic- and antidepressant-like effects in rat models of stress sensitivity.
    Walker MW; Wolinsky TD; Jubian V; Chandrasena G; Zhong H; Huang X; Miller S; Hegde LG; Marsteller DA; Marzabadi MR; Papp M; Overstreet DH; Gerald CP; Craig DA
    J Pharmacol Exp Ther; 2009 Mar; 328(3):900-11. PubMed ID: 19098165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze.
    Bacchi F; Mathé AA; Jiménez P; Stasi L; Arban R; Gerrard P; Caberlotto L
    Peptides; 2006 Dec; 27(12):3202-7. PubMed ID: 16959374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDF has found its receptor.
    Helfrich-Förster C
    Neuron; 2005 Oct; 48(2):161-3. PubMed ID: 16242393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrus variation in anxiolytic-like effects of intra-lateral septal infusions of the neuropeptide Y in Wistar rats in two animal models of anxiety-like behavior.
    Molina-Hernández M; Olivera-Lopez JI; Patricia Tellez-Alcántara N; Pérez-García J; Teresa Jaramillo M
    Peptides; 2006 Nov; 27(11):2722-30. PubMed ID: 16806581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Functional involvement of endogenous anxiogenic neuropeptide in brains].
    Katsura M; Ohkuma S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Jun; 24(3):119-23. PubMed ID: 15291240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of human and murine neuropeptide s receptor variants.
    Reinscheid RK; Xu YL; Okamura N; Zeng J; Chung S; Pai R; Wang Z; Civelli O
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1338-45. PubMed ID: 16144971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.